Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5 CAD
0.78%
Updated:
May 10, 2024
Immunoprecise Antibodies Ltd
Interest Income Expense
|
Immunoprecise Antibodies Ltd
Interest Income Expense Peer Comparison
Comparables:
ABCL
ARCH
RP
IOT
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Interest Income Expense
-CA$1.6m
|
CAGR 3-Years
-171%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Interest Income Expense
$46.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Interest Income Expense
-CA$453.4k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-46%
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Interest Income Expense
-CA$395.6k
|
CAGR 3-Years
-146%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-29%
|
|
|
Innovotech Inc
XTSX:IOT
|
Interest Income Expense
CA$120.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immunoprecise Antibodies Ltd's Interest Income Expense?
Interest Income Expense
-1.6m
CAD
-1.6m
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Interest Income Expense amounts to -1.6m CAD.
What is Immunoprecise Antibodies Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-171%
-171%
Over the last year, the Interest Income Expense growth was -354%. The average annual Interest Income Expense growth rates for Immunoprecise Antibodies Ltd have been -171% over the past three years .
You don't have any saved screeners yet
